Final results of a multicenter phase 1 study of lenalidomide in patients with relapsed or refractory chronic lymphocytic leukemia

Clemens Martin Wendtner, Peter Hillmen, Daruka Mahadevan, Andreas Bhler, Lutz Uharek, Steven Coutré, Olga Frankfurt, Adrian Bloor, Francesc Bosch, Richard R. Furman, Eva Kimby, John G. Gribben, Marco Gobbi, Luke Dreisbach, David D. Hurd, Mikkael A. Sekeres, Alessandra Ferrajoli, Sheetal Shah, Jennie Zhang, Laure Moutouh-De ParsevalMichael Hallek, Nyla A. Heerema, Stephan Stilgenbauer, Asher A. Chanan-Khan

Producción científica: Article › revisión exhaustiva

52 Citas (Scopus)

Huella

Profundice en los temas de investigación de 'Final results of a multicenter phase 1 study of lenalidomide in patients with relapsed or refractory chronic lymphocytic leukemia'. En conjunto forman una huella única.

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology